Copyright
©The Author(s) 2017.
World J Gastroenterol. May 28, 2017; 23(20): 3721-3729
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3721
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3721
Table 1 Proliferating cell nuclear antigen and E-cadherin labeling indexes in normal gastric tissues and diseased tissues
| Tissue type | Number of cases | PCNA labeling index | E-cadherin labeling index |
| Normal gastric tissue | 40 | 1.37 ± 0.32 | 22.34 ± 6.23 |
| Intestinal metaplasia | 38 | 11.53 ± 3.38 | 13.92 ± 4.34 |
| Dysplasia | 42 | 14.34 ± 4.71 | 7.84 ± 2.08 |
| Gastric cancer | 66 | 44.50 ± 9.85 | 1.68 ± 0.47 |
| F-value | - | 4.170 | 5.181 |
| P-value | - | 0.018 | 0.002 |
| Comparison of gastric cancer and dysplasia | |||
| Q-value | -18.519 | 23.204 | |
| P-value | 0.000 | 0.000 | |
- Citation: Hu L, Li HL, Li WF, Chen JM, Yang JT, Gu JJ, Xin L. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma. World J Gastroenterol 2017; 23(20): 3721-3729
- URL: https://www.wjgnet.com/1007-9327/full/v23/i20/3721.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i20.3721